383 related articles for article (PubMed ID: 20501720)
1. Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation.
Tsuboyama T; Onishi H; Kim T; Akita H; Hori M; Tatsumi M; Nakamoto A; Nagano H; Matsuura N; Wakasa K; Tomoda K
Radiology; 2010 Jun; 255(3):824-33. PubMed ID: 20501720
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.
Kitao A; Zen Y; Matsui O; Gabata T; Kobayashi S; Koda W; Kozaka K; Yoneda N; Yamashita T; Kaneko S; Nakanuma Y
Radiology; 2010 Sep; 256(3):817-26. PubMed ID: 20663969
[TBL] [Abstract][Full Text] [Related]
3. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker.
Choi JW; Lee JM; Kim SJ; Yoon JH; Baek JH; Han JK; Choi BI
Radiology; 2013 Jun; 267(3):776-86. PubMed ID: 23401584
[TBL] [Abstract][Full Text] [Related]
6. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
[TBL] [Abstract][Full Text] [Related]
7. Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.
Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
Radiology; 2014 Jun; 271(3):748-60. PubMed ID: 24588677
[TBL] [Abstract][Full Text] [Related]
8. OATP1B3 expression is strongly associated with Wnt/β-catenin signalling and represents the transporter of gadoxetic acid in hepatocellular carcinoma.
Ueno A; Masugi Y; Yamazaki K; Komuta M; Effendi K; Tanami Y; Tsujikawa H; Tanimoto A; Okuda S; Itano O; Kitagawa Y; Kuribayashi S; Sakamoto M
J Hepatol; 2014 Nov; 61(5):1080-7. PubMed ID: 24946283
[TBL] [Abstract][Full Text] [Related]
9. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images.
Kang Y; Lee JM; Kim SH; Han JK; Choi BI
Radiology; 2012 Sep; 264(3):751-60. PubMed ID: 22798225
[TBL] [Abstract][Full Text] [Related]
10. Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.
Ahn SS; Kim MJ; Lim JS; Hong HS; Chung YE; Choi JY
Radiology; 2010 May; 255(2):459-66. PubMed ID: 20413759
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT--initial observations.
Huppertz A; Haraida S; Kraus A; Zech CJ; Scheidler J; Breuer J; Helmberger TK; Reiser MF
Radiology; 2005 Feb; 234(2):468-78. PubMed ID: 15591431
[TBL] [Abstract][Full Text] [Related]
12. Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns.
Park MJ; Kim YK; Lee MW; Lee WJ; Kim YS; Kim SH; Choi D; Rhim H
Radiology; 2012 Sep; 264(3):761-70. PubMed ID: 22843769
[TBL] [Abstract][Full Text] [Related]
13. Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC.
Kim YK; Lee WJ; Park MJ; Kim SH; Rhim H; Choi D
Radiology; 2012 Oct; 265(1):104-14. PubMed ID: 22891358
[TBL] [Abstract][Full Text] [Related]
14. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
Kim JE; Kim SH; Lee SJ; Rhim H
AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265
[TBL] [Abstract][Full Text] [Related]
15. Gadoxetic acid-enhanced MR imaging for hepatocellular carcinoma: molecular and genetic background.
Kitao A; Matsui O; Yoneda N; Kozaka K; Kobayashi S; Koda W; Inoue D; Ogi T; Yoshida K; Gabata T
Eur Radiol; 2020 Jun; 30(6):3438-3447. PubMed ID: 32064560
[TBL] [Abstract][Full Text] [Related]
16. Cirrhotic rat liver: reference to transporter activity and morphologic changes in bile canaliculi--gadoxetic acid-enhanced MR imaging.
Tsuda N; Matsui O
Radiology; 2010 Sep; 256(3):767-73. PubMed ID: 20663976
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.
Suh YJ; Kim MJ; Choi JY; Park YN; Park MS; Kim KW
AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994
[TBL] [Abstract][Full Text] [Related]
18. Morphologic and Molecular Features of Hepatocellular Adenoma with Gadoxetic Acid-enhanced MR Imaging.
Ba-Ssalamah A; Antunes C; Feier D; Bastati N; Hodge JC; Stift J; Cipriano MA; Wrba F; Trauner M; Herold CJ; Caseiro-Alves F
Radiology; 2015 Oct; 277(1):104-13. PubMed ID: 25985059
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular Carcinoma with β-Catenin Mutation: Imaging and Pathologic Characteristics.
Kitao A; Matsui O; Yoneda N; Kozaka K; Kobayashi S; Sanada J; Koda W; Minami T; Inoue D; Yoshida K; Yamashita T; Yamashita T; Kaneko S; Takamura H; Ohta T; Ikeda H; Nakanuma Y; Kita R; Gabata T
Radiology; 2015 Jun; 275(3):708-17. PubMed ID: 25668519
[TBL] [Abstract][Full Text] [Related]
20. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
Jang KM; Kim SH; Kim YK; Choi D
Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
